/RLS.ST
RLS.ST Stock - RLS Global AB (publ)
Healthcare|Drug Manufacturers - Specialty & GenericSTO
$0.45-0.89%
$0.00 (-0.89%) • Jul 12
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.97
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.49
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RLS.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.44 – $0.45
TARGET (TP)$0.51
STOP LOSS$0.41
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.57
52W High$0.45
52W Low$0.45
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $1.20M | $653,000 | $2.04M | $1.02M | $2.62M |
| Gross Profit | $-411,000 | $-459,000 | $679,000 | $-157,000 | $1.37M |
| Gross Margin | -34.3% | -70.3% | 33.2% | -15.3% | 52.3% |
| Operating Income | $-24,368,000 | $-11,021,000 | $-24,386,000 | $-26,781,000 | $-21,889,657 |
| Net Income | $-24,367,000 | $-11,457,000 | $-20,534,000 | $-27,291,000 | $-21,891,989 |
| Net Margin | -2034.0% | -1754.5% | -1005.1% | -2667.7% | -835.6% |
| EPS | $-0.35 | $-0.17 | $-0.31 | $-0.45 | $-0.37 |
Company Overview
RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. The company was founded in 1996 and is based in Mölndal, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RLS.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.09
Q3 2023
EPS Surprise History
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Aug 25, 2023 | — | $-0.09 | — | — |
Q2 2023 | May 31, 2023 | — | $-0.09 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.11 | — | — |
Q4 2022 | Nov 24, 2022 | — | $-0.08 | — | — |
Q3 2022 | Aug 26, 2022 | — | $-0.09 | — | — |
Q2 2022 | May 11, 2022 | — | $-0.08 | — | — |
Q1 2022 | Feb 25, 2022 | — | $-0.11 | — | — |
Q4 2021 | Nov 12, 2021 | — | $-0.09 | — | — |
Q3 2021 | Jul 16, 2021 | — | $0.13 | — | — |
Q2 2021 | May 7, 2021 | — | $-0.09 | — | — |
Q1 2021 | Feb 10, 2021 | — | $-0.11 | — | — |
Q4 2020 | Nov 12, 2020 | — | $-0.08 | — | — |
Q3 2020 | Jul 17, 2020 | — | $-0.08 | — | — |
Q2 2020 | May 15, 2020 | — | $-0.06 | — | — |
Q1 2020 | Feb 14, 2020 | — | $-0.11 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.15 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.10 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.10 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.10 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.08 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RLS.ST
What is RLS.ST's current stock price?
RLS Global AB (publ) (RLS.ST) is currently trading at $0.45 per share. The stock has moved -0.89% today.
What is the analyst price target for RLS.ST?
No analyst price targets are currently available for this stock.
What sector is RLS Global AB (publ) in?
RLS Global AB (publ) operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the STO exchange.
What is RLS.ST's market cap?
RLS Global AB (publ) has a market capitalization of $0.04 billion, making it a small-cap company.
Does RLS.ST pay dividends?
No, RLS Global AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAEGIR.ST
AegirBio AB (publ)
$0.43
Mkt Cap: $0.0B
AMNI.ST
Amniotics AB (publ)
$0.01
Mkt Cap: $0.0B
COALA.ST
Coala-Life Group AB (publ)
$0.02
Mkt Cap: $0.0B
COMBI.ST
CombiGene AB (publ)
$2.47
Mkt Cap: $0.0B
DIABIO.ST
Diagonal Bio AB (publ)
$0.01
Mkt Cap: $0.0B
EMPLI.ST
Emplicure AB (publ)
$0.47
Mkt Cap: $0.0B
FRISQ.ST
FRISQ Holding AB (publ)
$0.70
Mkt Cap: $0.0B
KAN.ST
Kancera AB (publ)
$0.30
Mkt Cap: $0.0B
NEOD.ST
NeoDynamics AB (publ)
$0.90
Mkt Cap: $0.0B
PHARM.ST
Pharmiva AB (publ)
$0.56
Mkt Cap: $0.0B
Explore stocks similar to RLS.ST for comparison